USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ACCIUM BIOSCIENCES, INC.
Address:
550 17TH AVENUE
SUITE 550
SEATTLE, WA 98122
Phone:
N/A
URL:
N/A
EIN:
120117847
DUNS:
175977102
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $102,900.00 1

Award List:

Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$102,900.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): It is widely accepted that the existing clinical paradigm of one treatment fits all is a major factor in the lack of progress in the effective treatment of a highly heterogeneous diseases. We propose a new innovative cl inical paradigm that optimizes brain cancer… More